Please upgrade your browser.
Investors reacted favorably on Monday to Amgen Inc's $10.4 billion purchase of Onyx Pharmaceuticals Inc, which gives the world's largest biotech company full rights to a blood cancer drug with multibillion-dollar sales potential.
The company, which intends to use the funds for its Phase 3 clinical study of AGS-003, also plans to have data from its Phase 2b study of AGS-004 for the treatment of HIV in the first half of 2014.
A large study confirms the prognostic value of time to recurrence after surgery for renal cell carcinoma (RCC), and also suggests the need to reduce the threshold for early recurrence.
Tuesday’s entry in the Federal Register, spanning 75 pages, contains all of the fine print related to the individual mandate: who it applies to, who is exempted, and what kinds of insurance satisfy the government’s rules.
A first-ever technique using ice slush and minimally invasive robotic surgery to remove a particularly large type of kidney stone has been reported by urologists at Henry Ford Hospital.
NORD's state-by-state guide may help you!
Metastatic renal cell carcinoma: How to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor - Abstract
With seven agents approved for metastatic renal cell carcinoma (RCC) within the past few years, there has undoubtedly been progress in treating this disease.
“It’s going to be harder and harder and harder, particularly for (treatment centers) in rural and small communities, to stay afloat and continue to provide service for the patients when we continue to make cuts..."
Jessica's story will inspire you.
Doctors say a person suffering from urinary tract infection, resulting from kidney cancer can be easily treated and cured if the condition is diagnosed early.
|Powered by NeonCRM|